Fluence Pharma Private Limited, a active private limited company, was established on 05 March 2012 in Mumbai, Maharashtra, India. Engaging in hair care products within the trade sector, it holds CIN: U24233MH2012PTC227677. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Employing 11 professional, Its leadership includes Ashokkumar Bhusari (Director), Rajendrasingh Jalamsingh Rajput (Director), Abhijit Paul (Director). Past directors included Dhiren Krishna Paul, Promila Ashok Bhusari, Rajendrasingh Jalamsingh Rajput. It holds ₹5.22 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 810 Samarth Aishwarya Lokhandwala Complex, Off New Link Road,, Andheri(W), Mumbai, Maharashtra, 400053.
U24233MH2012PTC227677
227677
05 March 2012
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Fluence Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ashokkumar Bhusari | Director | 05 Mar 2012 | Current |
| Rajendrasingh Jalamsingh Rajput | Director | 18 Feb 2022 | Current |
| Abhijit Paul | Director | 18 Feb 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
| Pramod Abcsdd | Director | 18 Feb 2022 | Past |
| Pramod Abcsdd | Director | 31 Mar 2017 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Fluence Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 14.52% increase. The company also saw a substantial improvement in profitability, with a 15.47% increase in profit. The company's net worth Soared by an impressive increase of 50.52%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Fluence Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹52,200,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Jul 2023 | Axis Bank Limited | ₹3.75 Cr | Open |
| 18 Mar 2021 | Axis Bank Limited | ₹4.00 M | Open |
| 29 Oct 2015 | Axis Bank Limited | ₹1.07 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Fluence Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Fluence Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fluence Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Fluence Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
The activity Fluence Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was completed.
A charge with Axis Bank Limited amounted to Rs. 37.50 M with Charge ID 100760973 was registered on 28 Jul 2023. was recorded as a recent event.
Rajendrasingh Jalamsingh Rajput was appointed as a Director was appointed as a Director on 18 Feb 2022 & has been associated with this company since 3 years 10 months . was recorded as a recent event.
The activity Abhijit Paul was appointed as a Director was appointed as a Director on 18 Feb 2022 & has been associated with this company since 3 years 10 months . was completed.
The activity A charge with Axis Bank Limited amounted to Rs. 4.00 M with Charge ID 100427173 was registered on 18 Mar 2021. was completed.
The CIN of Fluence Pharma Private Limited is U24233MH2012PTC227677.
Fluence Pharma Private Limited is headquartered at 810 Samarth Aishwarya Lokhandwala Complex, Off New Link Road,, Andheri(W), Mumbai, Maharashtra, 400053.
Fluence Pharma Private Limited was incorporated on 05 March 2012.
The current directors of Fluence Pharma Private Limited are
The primary industry of Fluence Pharma Private Limited is Trade.
Fluence Pharma Private Limited is unlisted.
The authorized capital of Fluence Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Fluence Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX